Holen Sie sich die Stockscreener-App
4.24
9.28%
0.36
Schlusskurs vom Vortag:
$3.88
Offen:
$3.92
24-Stunden-Volumen:
1.37M
Relative Volume:
1.88
Marktkapitalisierung:
$235.19M
Einnahmen:
$163.78M
Nettoeinkommen (Verlust:
$25.88M
KGV:
6.5231
EPS:
0.65
Netto-Cashflow:
$-28.66M
1W Leistung:
+26.19%
1M Leistung:
+25.44%
6M Leistung:
+2.17%
1J Leistung:
-33.12%
1-Tages-Spanne:
$3.8705
$4.305
1-Wochen-Bereich:
$3.3287
$4.305
52-Wochen-Spanne:
$2.645
$8.275
Voyager Therapeutics Inc Stock (VYGR) Company Profile
Firmenname
Voyager Therapeutics Inc
Sektor
Branche
Telefon
857-259-5340
Adresse
75 HAYDEN AVENUE, LEXINGTON, MA
Vergleichen Sie VYGR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VYGR
Voyager Therapeutics Inc
|
4.24 | 215.22M | 163.78M | 25.88M | -28.66M | 0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-12-02 | Eingeleitet | Citigroup | Buy |
| 2024-11-29 | Fortgesetzt | Wedbush | Outperform |
| 2024-10-16 | Eingeleitet | Leerink Partners | Outperform |
| 2024-03-26 | Eingeleitet | Guggenheim | Buy |
| 2024-03-19 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-03-07 | Eingeleitet | Citigroup | Buy |
| 2024-01-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-05-10 | Eingeleitet | Truist | Buy |
| 2023-03-10 | Eingeleitet | Oppenheimer | Outperform |
| 2021-10-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-02-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-02-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-02-03 | Herabstufung | Wedbush | Outperform → Neutral |
| 2020-12-24 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2020-12-23 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-11-11 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-11-10 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-11-10 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-03-19 | Eingeleitet | The Benchmark Company | Buy |
| 2020-02-06 | Eingeleitet | Oppenheimer | Outperform |
| 2018-11-15 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-09-10 | Fortgesetzt | BTIG Research | Buy |
| 2018-09-10 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-06-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-03-12 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2018-03-12 | Herabstufung | Wedbush | Outperform → Neutral |
| 2018-02-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2017-11-28 | Fortgesetzt | Piper Jaffray | Overweight |
| 2017-10-31 | Eingeleitet | Robert W. Baird | Outperform |
| 2017-10-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2017-10-23 | Bestätigt | Stifel | Buy |
| 2017-10-12 | Eingeleitet | Raymond James | Outperform |
| 2017-08-17 | Eingeleitet | Evercore ISI | Outperform |
| 2017-07-28 | Fortgesetzt | Stifel | Buy |
Alle ansehen
Voyager Therapeutics Inc Aktie (VYGR) Neueste Nachrichten
Using Bollinger Bands to evaluate Voyager Therapeutics Inc.Market Performance Report & AI Powered Buy and Sell Recommendations - Newser
Is Voyager Therapeutics Inc. stock reversal real or fakePortfolio Risk Report & Weekly High Conviction Trade Ideas - Newser
What data driven models say about Voyager Therapeutics Inc.’s futureEarnings Recap Summary & High Conviction Buy Zone Alerts - Newser
Does Voyager Therapeutics Inc. stock benefit from AI growth2025 Retail Activity & Daily Market Momentum Tracking - خودرو بانک
Is Voyager Therapeutics Inc. benefiting from innovation trends2025 Technical Patterns & AI Powered Market Entry Strategies - خودرو بانک
Can Voyager Therapeutics Inc. continue delivering strong returnsMarket Sentiment Report & AI Enhanced Execution Alerts - خودرو بانک
Candlestick signals on Voyager Therapeutics Inc. stock todayPortfolio Value Report & AI Powered Market Trend Analysis - Newser
Is Voyager Therapeutics Inc.’s growth already priced inEntry Point & Fast Entry Momentum Alerts - خودرو بانک
Technical signs of recovery in Voyager Therapeutics Inc.Market Risk Report & Reliable Entry Point Trade Alerts - Newser
What is Voyager Therapeutics Inc.’s market positionLayoff News & Weekly Market Pulse Alerts - خودرو بانک
Regression analysis insights on Voyager Therapeutics Inc. performanceJuly 2025 Trade Ideas & Safe Swing Trade Setup Alerts - Newser
Applying Wyckoff theory to Voyager Therapeutics Inc. stockMarket Volume Summary & Expert Curated Trade Setups - Newser
Trend analysis for Voyager Therapeutics Inc. this weekJuly 2025 Gainers & Safe Capital Growth Stock Tips - Newser
Voyager Therapeutics Inc. stock daily chart insightsJuly 2025 Opening Moves & Free Weekly Watchlist of Top Performers - Newser
Can Voyager Therapeutics Inc. rally from current levelsJuly 2025 Pullbacks & AI Optimized Trading Strategy Guides - Newser
Volume spikes in Voyager Therapeutics Inc. stock – what they meanQuarterly Market Review & Step-by-Step Trade Execution Guides - Newser
What’s next for Voyager Therapeutics Inc. stock priceMarket Risk Report & AI Enhanced Execution Alerts - Newser
How to escape a deep drawdown in Voyager Therapeutics Inc.Buy Signal & Weekly Breakout Opportunity Watchlist - Newser
Reversal indicators forming on Voyager Therapeutics Inc. stockWeekly Market Outlook & Free Real-Time Volume Trigger Notifications - Newser
Detecting support and resistance levels for Voyager Therapeutics Inc.July 2025 Sector Moves & Daily Volume Surge Signals - Newser
Best data tools to analyze Voyager Therapeutics Inc. stockStock Surge & Momentum Based Trading Signals - Newser
Voyager Therapeutics Joins Citi’s Biopharma Conference 2025 - The Globe and Mail
Voyager Therapeutics Inc. stock trend forecastJuly 2025 Breakouts & Free Verified High Yield Trade Plans - Newser
Is Voyager Therapeutics Inc. stock influenced by commodity pricesM&A Rumor & Daily Profit Maximizing Tips - khodrobank.com
Can trapped investors hope for a rebound in Voyager Therapeutics Inc.July 2025 Levels & Verified Swing Trading Watchlist - Newser
Voyager Therapeutics: A High-Conviction Play in Neuro-Genetic Innovation - AInvest
Order Flow Trends Show Accumulation in Voyager Therapeutics Inc.Market Risk Summary & Verified Momentum Stock Ideas - beatles.ru
Voyager Therapeutics: Pioneering Non-Viral Delivery in Neurotherapeutics - AInvest
Voyager Therapeutics’ Strategic Momentum in Neurological Disease Innovation: Assessing the Investment Potential of Preclinical Pipeline and Non-Viral Delivery Platform - AInvest
Voyager Therapeutics Presents at Citi's Biopharma Back to School Conference - AInvest
Transcript : Voyager Therapeutics, Inc. Presents at Citi's Biopharma Back to School Conference, Sep-02-2025 04 - MarketScreener
What is the dividend yield of Voyager Therapeutics Inc.Quarterly Market Summary & Verified Momentum Stock Watchlist - خودرو بانک
Relative strength of Voyager Therapeutics Inc. in sector analysis2025 Historical Comparison & Growth Focused Investment Plans - Newser
Is There Enough Volume to Lift Voyager Therapeutics Inc.Market Weekly Review & Low Risk High Win Rate Stock Picks - beatles.ru
Market Leaders: Can Voyager Therapeutics Inc. be recession proofWeekly Profit Analysis & Weekly Watchlist for Hot Stocks - خودرو بانک
Can Voyager Therapeutics Inc. be recession proofPortfolio Performance Summary & Weekly Breakout Watchlists - خودرو بانک
Analyzing drawdowns of Voyager Therapeutics Inc. with statistical toolsMarket Activity Summary & Consistent Income Trade Recommendations - Newser
Published on: 2025-09-01 14:05:37 - Newser
Finanzdaten der Voyager Therapeutics Inc-Aktie (VYGR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):